Wealthcare Advisory Partners’s Editas Medicine EDIT Stock Holding History

Wealthcare Advisory Partners’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-140	Closed	-$3K	–	588
2020 Q1	$3K	Hold	140	–	–	﹤0.01%	1221
2019 Q4	$4K	Hold	140	–	–	﹤0.01%	1137
2019 Q3	$3K	Hold	140	–	–	﹤0.01%	1142
2019 Q2	$3K	Hold	140	–	–	﹤0.01%	1134
2019 Q1	$3K	Hold	140	–	–	﹤0.01%	1035
2018 Q4	$3K	Hold	140	–	–	﹤0.01%	1017
2018 Q3	$4K	Sell	140 -65	-32%	-$2.1K	﹤0.01%	1021
2018 Q2	$7K	Buy	205 +140	+215%	+$4.96K	﹤0.01%	917
2018 Q1	$2K	Hold	65	–	–	﹤0.01%	952
2017 Q4	$2K	Buy	+65	New	+$1.64K	﹤0.01%	913

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wealthcare Advisory Partners's EDIT Position: Q2 2020 in Review

Wealthcare Advisory Partners sold out of Editas Medicine (EDIT) in Q2 2020, closing a stake of 140 shares — an estimated $3K sold.

Wealthcare Advisory Partners first reported a position in EDIT in Q4 2017 and held it in 10 quarters. The position peaked at $7K in Q2 2018. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2020.

Wealthcare Advisory Partners reported no remaining Editas Medicine position as of Q2 2020 after selling out during the quarter.
Wealthcare Advisory Partners sold 140 Editas Medicine shares in Q2 2020, an estimated $3K.
Wealthcare Advisory Partners first reported a position in Editas Medicine in Q4 2017 and held it in 10 quarters.
Wealthcare Advisory Partners's Editas Medicine position peaked at $7K in Q2 2018.
238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2020, filed 29 Jul 2020.